Samuel Svensson

CEO at NEOGAP Therapeutics AB - Stockholm, Stockholm County, Sweden

Samuel Svensson's Colleagues at NEOGAP Therapeutics AB
Samuel Svensson's Contact Details
HQ
+46 73 354 21 94
Location
Sweden
Company
NEOGAP Therapeutics AB
Samuel Svensson's Company Details
NEOGAP Therapeutics AB logo, NEOGAP Therapeutics AB contact details

NEOGAP Therapeutics AB

Stockholm, Stockholm County, Sweden • 17 Employees
Pharmaceuticals

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden.  Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.

Details about NEOGAP Therapeutics AB
Frequently Asked Questions about Samuel Svensson
Samuel Svensson currently works for NEOGAP Therapeutics AB.
Samuel Svensson's role at NEOGAP Therapeutics AB is CEO.
Samuel Svensson's email address is ***@neogap.se. To view Samuel Svensson's full email address, please signup to ConnectPlex.
Samuel Svensson works in the Pharmaceuticals industry.
Samuel Svensson's colleagues at NEOGAP Therapeutics AB are Sofia Berglund and others.
Samuel Svensson's phone number is +46 73 354 21 94
See more information about Samuel Svensson